Skip to main content
. 2017 Jun 29;18(7):1390. doi: 10.3390/ijms18071390
AA arachidonic acid
AIDS acquired immunodeficiency syndrome
BBB blood–brain barrier
CCL2 C-C motif chemokine ligand 2
CNS central nervous system
CVD cardiovascular disease
DAG diacylglycerol
FA fatty acid
HAART highly active antiretroviral therapy
HAND HIV-associated neurocognitive disorder
HIV-1 human immunodeficiency virus type I
IP3 inositol 1,4,5-trisphosphate
LDL low-density lipoprotein
LPA lysophosphatidate
LPC lysophosphatidylcholine
Lp-PLA2 lipoprotein-associated phospholipase A2
LPS lipopolysaccharide
LT leukotriene
NF-kB nuclear factor kappa-light-chain-enhancer of activated B cells
NO nitric oxide
PAF platelet-activating factor
PC phosphatidylcholine
PC-PLC phosphatidylcholine specific phospholipase C
PG prostaglandin
PI phosphoinositide
PI-PLC phosphoinositide-specific phospholipase C
PL phospholipase
PLA2 phospholipase A2
cPLA2 cytosolic PLA2
iPLA2 Ca2+-insensitive phospholipase A2
sPLA2 secretory phospholipase A2
ROS reactive oxygen species
SIV simian immunodeficiency virus
TNF tumor necrosis factor